Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksYellow Cake Regulatory News (YCA)

Share Price Information for Yellow Cake (YCA)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 667.00
Bid: 668.50
Ask: 671.50
Change: -19.50 (-2.84%)
Spread: 3.00 (0.449%)
Open: 686.00
High: 686.00
Low: 667.00
Prev. Close: 686.50
YCA Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Changes to the Board of Directors

9 Nov 2022 09:29

RNS Number : 8301F
Yellow Cake PLC
09 November 2022
 

9 November 2022

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION (EU) NO 596/2014 WHICH IS PART OF UK LAW BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

 

 

Yellow Cake plc ("Yellow Cake" or the "Company")

Changes to the Board of Directors

 

Yellow Cake, a specialist company operating in the uranium sector holding physical uranium for the long term, is pleased to confirm the appointment of Claire Brazenall as an independent non-executive director with effect from 9 November 2022. Claire acts as in-house legal counsel and Client Director of Langham Hall Fund Management (Jersey) Limited, which provides administrative services to the Company.

Claire Brazenall (Legal name, Claire Le Quesne) has over 12 years of experience of the Jersey funds industry. Prior to joining Langham Hall Jersey in 2020, Ms. Brazenall spent 10 years in private practice with Carey Olsen Jersey LLP where she gained a wealth of experience of different fund structures and asset classes and was heavily involved in providing regulatory and structuring advice to a range of clients. During her time at Carey Olsen Jersey LLP, she was involved in the closings of over US$100bn of investor commitments into various fund structures.

Claire Brazenall has extensive experience in liaising with the Jersey Financial Services Commission ("JFSC") and The International Stock Exchange and has in-depth knowledge of the relevant Codes of Practice and Jersey financial services regulations. She is approved as a principal person by the JFSC and currently acts as a director on a number of regulated and unregulated funds and Special Purpose Vehicles ("SPV") boards of client companies.

Claire's appointment follows the resignation of Emily Manning as an independent non-executive director with effect from 8 November 2022. The Board would like to take this opportunity to express its sincere gratitude to Emily for her contributions to Yellow Cake.

Further information in relation to the Director appointment

Claire Brazenall

Claire Brazenall (aged 37) has confirmed that, other than the information disclosed below, there are no matters to be disclosed under Rule 17 and paragraph (g) of Schedule 2 of the AIM Rules.

Current directorships

Company name

Anglo Securities Poole Limited

ASF UK I (Trustee) Limited

ASF UK Industrial Portfolio 2 Trustee 1 Limited

ASF UK Industrial Portfolio 2 Trustee 2 Limited

ASF UK Industrial Portfolio Trustee 1 Limited

ASF UK Industrial Portfolio Trustee 2 Limited

ASF UK Touchwood Trustee 1 Limited

ASF UK Touchwood Trustee 2 Limited

Bolingbroke Office Trustee 1 Limited

Bolingbroke Office Trustee 2 Limited

Carbon Exposure PLC

Eagle Street Partners ACO Holdings 2 Limited

Eagle Street Partners ACO Holdings 3 Limited

Eagle Street Partners ACO Holdings 4 Limited

Eagle Street Partners ACO Holdings Limited

Eagle Street Partners ACO1 Limited

Eagle Street Partners ACO2 Limited

Eagle Street Partners ACO3 Limited

Eagle Street Partners ACO4 Limited

Eagle Street Partners CL Limited

Eagle Street Partners Group Limited

Eagle Street Partners Holdings Limited

Hawthorn Residential Fund GP Ltd

Postbridge Jersey Limited

Reading Nominee No.1 Limited

Reading Nominee No.2 Limited

Reading Trustee Limited

Resident Space Advisors Limited

Student Homes GP Limited

Willow Brook Centre Bristol Limited

Crescendo Indigo Net Lease GP Limited

Patron Capital GP V Limited

Patron Capital GP VI Limited

Patron Capital GP VII Limited

 

Previous directorships held in the last 5 years

N/A

Shareholding in the Company 

Nil.

 

 

ENQUIRIES: 

 

Yellow Cake plc

Andre Liebenberg, CEO

Carole Whittall, CFO

Tel: +44 (0) 153 488 5200

Nominated Adviser and Joint Broker: Canaccord Genuity Limited

Henry Fitzgerald-O'Connor

James Asensio

Gordon Hamilton

Tel: +44 (0) 207 523 8000

Joint Broker: Berenberg

Matthew Armitt

Jennifer Lee

Detlir Elezi

Tel: +44 (0) 203 207 7800

Financial Adviser: Bacchus Capital Advisers

Peter Bacchus

Richard Allan

Tel: +44 (0) 203 848 1640

Communications Adviser: Powerscourt

Peter Ogden

Molly Melville

Tel: +44 (0) 7793 858 211

 

 

ABOUT YELLOW CAKE

Yellow Cake is a London-quoted company, headquartered in Jersey, which offers exposure to the uranium spot price. This is achieved through its strategy of buying and holding physical triuranium octoxide ("U3O8"). It may also seek to add value through other uranium related activities. Yellow Cake seeks to generate returns for shareholders through the appreciation of the value of its holding of U3O8 and its other uranium related activities in a rising uranium price environment. The business is differentiated from its peers by its ten-year Framework Agreement for the supply of U3O8 with Kazatomprom, the world's largest uranium producer. Yellow Cake currently holds 18.81 million pounds of U3O8, all of which is held in storage in Canada and France. 

 

FORWARD LOOKING STATEMENTS

Certain statements contained herein are forward looking statements and are based on current expectations, estimates and projections about the potential returns of the Company and the industry and markets in which the Company will operate, the Directors' beliefs and assumptions made by the Directors. Words such as "expects", "anticipates", "should", "intends", "plans", "believes", "seeks", "estimates", "projects", "pipeline", "aims", "may", "targets", "would", "could" and variations of such words and similar expressions are intended to identify such forward looking statements and expectations. These statements are not guarantees of future performance or the ability to identify and consummate investments and involve certain risks, uncertainties and assumptions that are difficult to predict, qualify or quantify. Therefore, actual outcomes and results may differ materially from what is expressed in such forward looking statements or expectations. Among the factors that could cause actual results to differ materially are: uranium price volatility, difficulty in sourcing opportunities to buy or sell U3O8, foreign exchange rates, changes in political and economic conditions, competition from other energy sources, nuclear accident, loss of key personnel or termination of the services agreement with 308 Services Limited, changes in the legal or regulatory environment, insolvency of counterparties to the Company's material contracts or breach of such material contracts by such counterparties. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to disseminate any updates or revisions to any forward looking statements contained herein to reflect any change in the Company's expectations with regard thereto or any change in events, conditions or circumstances on which any such statements are based unless required to do so by applicable law or the AIM Rules.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAUPGMPGUPPUBB
Date   Source Headline
29th Apr 20247:00 amRNSQuarterly Operating Update
12th Mar 20248:34 amRNSTR1: Notification of major holdings
5th Mar 20247:00 amRNSReview of Long-term Incentive Plan
9th Feb 20242:19 pmRNSTR1: Notification of major holdings
2nd Feb 20242:20 pmRNSTR1: Notification of major holdings
24th Jan 20247:00 amRNSQuarterly Operating Update
19th Jan 20247:00 amRNSYellow Cake plc named to 2024 OTCQX Best 50
8th Jan 20247:00 amRNSTR1: Notification of Major Holdings
6th Dec 20237:00 amRNSInterim Financial Report
31st Oct 20237:00 amRNSQuarterly Operating Update
6th Oct 202311:29 amRNSTR-1: Notification of major holdings
2nd Oct 20237:00 amRNSDELIVERY OF 1,350,000 LB OF U3O8
28th Sep 20237:03 amRNSResults of Placing
27th Sep 20236:17 pmRNSPROPOSED PURCHASE OF URANIUM AND PLACING
18th Sep 20237:00 amRNSTR-1: Notification of major holdings
15th Sep 20238:30 amRNSTR-1: Notification of major holdings
31st Jul 20237:00 amRNSQUARTERLY OPERATING UPDATE
26th Jul 20239:04 amRNSRe-issue of Treasury Shares
25th Jul 20237:00 amRNSAGM Notice and Publication of 2023 Annual Report
20th Jul 20237:00 amRNSExercise of Share Options
19th Jul 20237:00 amRNSAnnual Results for the year ended 31 March 2023
5th Jun 20237:00 amRNSRe-issue of Treasury Shares
25th May 20237:00 amRNSExercise of Share Options
15th May 20237:00 amRNSChange of Registered Office
26th Apr 20237:00 amRNSQUARTERLY OPERATING UPDATE
21st Feb 20237:00 amRNSTR-1: Notification of Major Holdings
9th Feb 20237:00 amRNSExercise of Kazatomprom 2022 Option
3rd Feb 20237:00 amRNSResults of Placing
2nd Feb 20234:52 pmRNSPROPOSED PURCHASE OF URANIUM AND PLACING
2nd Feb 20234:35 pmRNSQUARTERLY OPERATING UPDATE
28th Dec 20227:00 amRNSYELLOW CAKE RECEIVES DTC ELIGIBILITY
7th Dec 20227:00 amRNSInterim Report
9th Nov 20229:29 amRNSChanges to the Board of Directors
4th Nov 20227:00 amRNSAward of Share Options
31st Oct 20227:00 amRNSQuarterly Operating Update
7th Sep 202211:27 amRNSResults of 2022 Annual General Meeting
29th Jul 20227:00 amRNSNotice of AGM & Publication of 2022 Annual Report
28th Jul 20227:00 amRNSQUARTERLY OPERATING UPDATE
22nd Jul 20227:00 amRNSAnnual Results for the year ended 31 March 2022
15th Jul 20229:00 amRNSTR1: Notification of Major Holdings
1st Jul 20227:00 amRNSDELIVERY OF 950,000 LB OF U3O8
22nd Jun 20227:00 amRNSCOMMENCEMENT OF TRADING ON OTCQX
20th May 20227:00 amRNSDELIVERY OF URANIUM
10th May 20227:00 amRNSTR-1: Notification of major holdings
9th May 20227:00 amRNSCompletion of Buyback Programme
6th May 20223:10 pmRNSTransaction in Own Shares
6th May 20227:00 amRNSTransaction in Own Shares
5th May 20227:00 amRNSTransaction in Own Shares
4th May 202211:53 amRNSShare Buyback Programme extension
4th May 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.